MA SONGJIANG (President) sold 0.1% of their position (2.02K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $21.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/16/2025ACC: 0001140361-25-019468
DirectorOfficer· President
Since Oct 2023
-2.02K
Net shares
Net seller
$21.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.02K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−20.00
Price / share
$11.30
Trade value
$226.00
% of position
0.0%
5/14/2025
2.82M→2.82M
Common Stock
Indirect
Shares
−2K
Price / share
$10.68
Trade value
$21.36K
% of position
0.1%
5/15/2025
2.82M→2.82M
Total
Net shares
−2.02K
Net value
-$21.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/14/2025 | S · Sale | −20.00 | $11.30 | $226.00 | 0.0% | 2.82M | 2.82M |
| Common Stock Indirect | 5/15/2025 | S · Sale | −2K | $10.68 | $21.36K | 0.1% | 2.82M | 2.82M |
| Total | −2.02K | -$21.59K | ||||||
Derivative Transactions0
No derivative transactions reported